NO995721L - Leukotrien-B4-derivater, spesielt oksim-LTB4-antagonister - Google Patents
Leukotrien-B4-derivater, spesielt oksim-LTB4-antagonisterInfo
- Publication number
- NO995721L NO995721L NO995721A NO995721A NO995721L NO 995721 L NO995721 L NO 995721L NO 995721 A NO995721 A NO 995721A NO 995721 A NO995721 A NO 995721A NO 995721 L NO995721 L NO 995721L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- pct
- derivatives
- symbolizes
- cycloalkyl
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- VNYSSYRCGWBHLG-AMOLWHMGSA-N leukotriene B4 Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-AMOLWHMGSA-N 0.000 title 1
- 150000002615 leukotriene B4 derivatives Chemical class 0.000 title 1
- 150000002923 oximes Chemical class 0.000 title 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 abstract 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 150000001491 aromatic compounds Chemical class 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 150000002390 heteroarenes Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 150000002617 leukotrienes Chemical class 0.000 abstract 1
- -1 organic acid radical Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
- C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19722848A DE19722848A1 (de) | 1997-05-23 | 1997-05-23 | Leukotrien-B¶4¶-Derivate, insbesondere Oximo-LTB¶4¶-Antagonisten |
| PCT/EP1998/003139 WO1998052915A2 (de) | 1997-05-23 | 1998-05-22 | Leukotrien-b4-derivate, insbesondere oximo-ltb4-antagonisten |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO995721D0 NO995721D0 (no) | 1999-11-22 |
| NO995721L true NO995721L (no) | 2000-01-20 |
| NO317808B1 NO317808B1 (no) | 2004-12-13 |
Family
ID=7831039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19995721A NO317808B1 (no) | 1997-05-23 | 1999-11-22 | Leukotrien-B<N>4</N>-derivater, spesielt oksim-LTB<N>4</N>-antagonister, fremgangsmate for fremstilling av disse og farmasoytiske preparater som inneholder dem |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6160012A (no) |
| EP (1) | EP0983235B1 (no) |
| JP (1) | JP2002500646A (no) |
| KR (1) | KR20010012843A (no) |
| AT (1) | ATE220060T1 (no) |
| AU (1) | AU736132B2 (no) |
| CA (1) | CA2291123A1 (no) |
| DE (2) | DE19722848A1 (no) |
| NO (1) | NO317808B1 (no) |
| WO (1) | WO1998052915A2 (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8729108B2 (en) * | 2008-06-17 | 2014-05-20 | Christopher J Dannaker | Waterborne topical compositions for the delivery of active ingredients such as azelaic acid |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2008573B (en) * | 1977-10-19 | 1982-02-03 | Shell Int Research | Preparation of carvone |
| HU180739B (en) * | 1979-07-03 | 1983-04-29 | Egyt Gyogyszervegyeszeti Gyar | Process for producing basic oxime-ethers |
| HU212415B (en) * | 1989-08-25 | 1996-06-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing new cyclic oxym derivatives and pharmaceutical compositions containing them as active components |
| DE4108351A1 (de) * | 1991-03-12 | 1992-09-17 | Schering Ag | Neue leukotrien-b(pfeil abwaerts)4(pfeil abwaerts)-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| DE4139868A1 (de) * | 1991-11-29 | 1993-10-14 | Schering Ag | Neue Leukotrien-B¶4¶-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| CA2100918C (en) * | 1992-07-21 | 1997-01-21 | Nobuyuki Hamanaka | Oxime derivative |
| DE4227790A1 (de) * | 1992-08-19 | 1994-02-24 | Schering Ag | Neue Leukotrien-B¶4¶-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE4236540A1 (de) * | 1992-10-22 | 1994-06-23 | Schering Ag | Neue Leukotrien-B¶4¶-Derivate, Verfahren zu ihrer H erstellung und ihre Verwendung als Arzneimittel |
| DE4242390A1 (de) * | 1992-12-09 | 1994-06-16 | Schering Ag | Neue Leukotiren-B¶4¶-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| ES2118379T3 (es) * | 1994-01-27 | 1998-09-16 | Schering Ag | Nuevos derivados de leucotrieno b4, procedimiento para su preparacion y su utilizacion como medicamentos. |
| WO1998052195A1 (en) * | 1997-05-13 | 1998-11-19 | Iomega Corporation | Method for use in a disk drive to calibrate demodulator gain without a/d conversion of cpes signal |
-
1997
- 1997-05-23 DE DE19722848A patent/DE19722848A1/de not_active Withdrawn
-
1998
- 1998-05-22 CA CA002291123A patent/CA2291123A1/en not_active Abandoned
- 1998-05-22 WO PCT/EP1998/003139 patent/WO1998052915A2/de not_active Application Discontinuation
- 1998-05-22 AU AU81071/98A patent/AU736132B2/en not_active Ceased
- 1998-05-22 DE DE59804682T patent/DE59804682D1/de not_active Expired - Fee Related
- 1998-05-22 AT AT98930743T patent/ATE220060T1/de not_active IP Right Cessation
- 1998-05-22 US US09/423,336 patent/US6160012A/en not_active Expired - Fee Related
- 1998-05-22 EP EP98930743A patent/EP0983235B1/de not_active Expired - Lifetime
- 1998-05-22 KR KR1019997010808A patent/KR20010012843A/ko not_active Application Discontinuation
- 1998-05-22 JP JP54998998A patent/JP2002500646A/ja active Pending
-
1999
- 1999-11-22 NO NO19995721A patent/NO317808B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010012843A (ko) | 2001-02-26 |
| ATE220060T1 (de) | 2002-07-15 |
| WO1998052915A2 (de) | 1998-11-26 |
| NO317808B1 (no) | 2004-12-13 |
| JP2002500646A (ja) | 2002-01-08 |
| AU8107198A (en) | 1998-12-11 |
| EP0983235A2 (de) | 2000-03-08 |
| US6160012A (en) | 2000-12-12 |
| AU736132B2 (en) | 2001-07-26 |
| NO995721D0 (no) | 1999-11-22 |
| CA2291123A1 (en) | 1998-11-26 |
| DE59804682D1 (de) | 2002-08-08 |
| DE19722848A1 (de) | 1998-11-26 |
| EP0983235B1 (de) | 2002-07-03 |
| WO1998052915A3 (de) | 1999-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2144403T3 (es) | Derivados de tiazol como inhibidores de oxigeno activo. | |
| ES2061890T3 (es) | Soluciones acuosas estabilizadas de 3-isotiazolinonas. | |
| ATE181551T1 (de) | Taxol-derivate | |
| ATE167476T1 (de) | Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel. | |
| ATE270103T1 (de) | Aminophenoxyessigsäure derivate als neuroschützende mittel | |
| KR890003720A (ko) | 벤조티아졸 및 그를 유효성분으로 함유하는 항류머티스제 | |
| GB2306958B (en) | Oximesulfonic acid esters and the use thereof as latent sulfonic acids | |
| ATE329894T1 (de) | Verwendung von cyclopropancyclus enthaltenden carbonsäureverbindungen als medikament | |
| NO952207L (no) | Anvendelse av 2-amino-6-A-propylamino-4,5,6,7-tetrahydrobenzotiazol (pramipexol) som et antidepresivt legemiddel | |
| PT952974E (pt) | Derivados bifenilicos substituidos por um radical aromatico ou heteroaromatico e composicoes farmaceuticas e cosmeticas que os contem | |
| DE59407431D1 (de) | Verwendung aromatischer Carbonsäurederivate zur Herstellung von pharmazeutischen Präparaten | |
| EA200100947A1 (ru) | Жевательные таблетки с высоким содержанием n-ацетилцистеина | |
| TR199800714T2 (xx) | Yeni $(3-Alkoksi-fenoksi)-etil]-dialkilamin t�revleri. | |
| NO995721L (no) | Leukotrien-B4-derivater, spesielt oksim-LTB4-antagonister | |
| DE50101861D1 (de) | Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung | |
| ATE244232T1 (de) | (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer | |
| ATE256466T1 (de) | Verwendung von manzaminen als entzündungshemmende mittel | |
| NO971991L (no) | Heterosyklus-substituerte propensyrederivater som NMDA-antagonister | |
| NO963854D0 (no) | Okulart spenningsnedsettende middel | |
| CO5700816A2 (es) | Derivados de aralquilo sustituidos | |
| ES2157345T3 (es) | Compuestos de gamma-dicetona con actividad inhibidora contra la agregacion de plaquetas. | |
| GB1065965A (en) | Dibenzocyclooctenes | |
| IT1261662B (it) | Derivati xantonici, loro preparazione ed attivita' | |
| CO5560539A2 (es) | Derivados de 2-hidroxi-2-metil-3,3,3-trifluoropropanamida n-fenilo sustituida que elevan la actividad de piruvato deshidrogenasa | |
| ATE92031T1 (de) | Neue leukotrien-b 4 -derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. |